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Neurulation is critical for the proper development of the central nervous system during 
embryogenesis. This process requires coordinated morphogenetic movements driven by localized 
cell movements. The key morphogenetic process responsible for lengthening the neural plate is 
convergent extension. During convergent extension medially oriented cell polarity, protrusive 
activity, and motility are thought to generate forces through cell intercalation resulting in stiffer 
elongating tissues. My research determines that forces that help shape the neural plate arise from 
morphogenetic movements in the neural tissue and determines PCP signaling regulates tissue 
stiffness in the neural ectoderm. We have established an experimental system sensitive enough to 
evaluate the stiffness of Xenopus neural tissue. Stiffness is measured by gluing two fine wires onto 
neural explants from an early gastrula stage Xenopus laevis embryo. The wires stretch the tissue at a 
constant strain rate using a real‐time image‐based feedback system and stiffness is determined by 
measuring the deflection of one wire. Measurements obtained from control embryos prior to 
neurulation estimate tissue stiffness at approximately 12.7 ± 0.53 mN/m in both mediolateral and 
anteroposterior directions. Stiffness measurements double in early neurula embryos (P < 0.05). 
Mediolateral stiffness, 24.9 ±6.2 mN/m, is significantly greater than anteroposterior stiffness, 21.4 
±5.3 mN/m (P < 0.05). These trends are strengthened in normalized data to reduce clutch‐to‐clutch 
variation. Expressions of dominant‐negative Wnt11, Fz7, and Dsh constructs successfully disrupt 
neurulation by interfering with the PCP pathway.  Changes in stiffness of the neural plate were 
measured and show reduced stiffness at early neurula stage in both mediolateral and 
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List of Abbreviations 
 
AP Anteroposterior, referring to the anterior‐posterior or rostral‐caudal axis 
CE Convergent extension, the active medial‐lateral intercalation of 
neuroepithelium and dorsal mesoderm that extends the embryo in the 
anterior‐posterior axis 
DFA Danilchik’s for Amy solution 
MBS Modified Barth’s Solution 
ML mediolateral, referring to the medial‐lateral axis 
PCP Planar Cell Polarity (Non‐canonical Wnt signaling) 
Stiffness The ability to resist deformation, specifically the ability of a material to resist 
changes in length when under lengthwise tension or compression, used 
generically to encompass both structural and material stiffness 
Structural stiffness – a geometry dependent term calculated as the change in 
force over the change in length.  Used to compare different structures of the 
same type 
Material stiffness – a geometry independent term generally referring to 
Young’s Modulus.  Used to compare different materials regardless of the type 
and geometry of the structures they are part of 
Strain (ε) A geometry independent measure of deformation, calculated as the change in 
length divided by original length for uniaxial tests.  This term is expressed as a 




Strain Rate The rate of change of strain, calculated as the change in strain divided by the 
elapsed time 
Stress (σ)  A geometry independent term calculated as the magnitude of the applied 
force divided by the area of the surface over which the force is applied.  The SI 
unit for stress is Pascals (Pa) which is equivalent to one Newton of force per 
square meter (N/m2) 
Tension 
(tensile force) 
The magnitude of pulling force on a material imposed by an outside object, 
measured in Newtons and is always parallel to the object on which it applies 
(opposite of compression) 
Young’s Modulus 
(E, modulus of 
elasticity) 
A measure of stiffness that describes the elastic properties of a solid 
undergoing uniaxial compression or tension measured in Pa or N/m2.  It is the 
ratio of the uniaxial stress over the uniaxial strain and can be experimentally 
determined from the slope of a stress‐strain curve created during tensile tests 














1.1 Biomechanics and Morphogenesis 
Morphogenesis is the rearrangement of cells and tissues to generate embryonic form. 
Morphogenesis is driven by changes in cell shape, cell adhesion, and cell migration. Cell 
rearrangements generate physical forces that lead to the mechanical deformations and bulk 
movement of tissues necessary for shaping the embryo (Trinkaus, 1984). The mechanical properties 
of tissues determine how tissues deform or resist deformation in response to generated forces. 
Biomechanics studies how these forces are generated and how they affect the mechanical 
properties of tissues. By studying the mechanical properties of tissues in conjunction with molecular 
manipulations that disrupt development we can describe how individual molecules contribute to the 
process of morphogenesis.  
 
1.2 Xenopus laevis Neurulation 
 During chordate embryogenesis, neurulation is the major morphogenetic event crucial for 
development of the central nervous system. In Xenopus neurulation begins with the thickening of 
the neuroepithelium, the inner layer of the dorsal ectoderm, to form the neural plate (Fig. 1.1A). 
Bending of the neural plate along the lateral margins, the lateral hingepoints, elevates the neural 
folds (Fig. 1.1B). Cell intercalation then draws the neural folds toward the midline, assisted by 
bending along the medial hingepoint (Fig. 1.1C). As the neural folds move medially, the neural plate 
and dorsal mesoderm narrow and lengthen along the anterior‐posterior axis. The neural folds 
subsequently meet at the midline and fuse to form a hollow neural tube (Wallingford, 2005, Fig. 
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1.1D). Apical constriction and cell intercalation are the primary morphogenetic processes 
responsible for generating the forces that bend, narrow, and lengthen the neural plate. 
 
1.2.1 Cell Shape Change: Apical Constriction 
Neural plate bending requires apical constriction of epithelial cells at the lateral and medial 
hingepoints. The molecular mechanism behind apical constriction is best described in Drosophila 
melanogaster. In Drosophila ventral mesoderm apical constriction is coordinated by actin‐myosin 
contractile rings in conjunction with increased cell‐cell adhesion at the apical surface (Fig. 1.2 A, B) 
(Barmchi et al, 2005; Kolsch et al, 2007). As the apical surface of the cells shrink, the cells become 
wedge shaped. Increased apical lateral adhesion keeps the cells tightly adherent and the changes in 
cell shape bend the tissue. While the molecular basis of apical constriction is not well characterized, 
there is evidence in vertebrates that both the contraction of the cytoskeleton and accumulation of 
actin at the apical surface are tightly regulated. In mouse neural tissue, integrin activation activates 
p190RhoGAP regulation of the small GTPase Rho through GTPase activating proteins (GAPs) leading 
to actin polymerization and cadherin‐mediated cell‐cell adhesions. Shroom is an actin binding 
protein required for apical actin accumulation. The over‐expression of shroom induces ectopic apical 
actin accumulation and subsequent apical constriction (Haigo et al, 2003). Deletion mutations of 
p190RhoGAP and shroom genes result in the failure of neural plate bending and neural tube closure 
in Xenopus (Brouns et al, 2000; Haigo et al, 2003). In addition, basal localization of nuclei and active 
apico‐basal microtubule elongation may also contribute to apical constriction by allowing cytoplasm 













Figure 1.1 Morphogenetic movements of Xenopus laevis neurulation. (A) Thickening of the 
neuroepithelium to form the neural plate with overlying epithelium and underlying prenotochord 
mesodermal cells (pink).  (B) Lateral hingepoint bending and elevation of the neural folds. (C) Neural 
folds migrate medially toward the midline assisted by medial hingepoint bending. (D) Neural folds 



















Figure 1.2 Mechanisms for cell wedging during apical constriction. (A) Apical constriction 
occurs through actin‐myosin contraction (green) at the apical surface. (B) Tissue bending may be 
assisted by increased inter‐cellular adhesion (red) at the apical lateral surface as cells change shape. 
(C) Increases in cell height may also assist in cell wedging as apico‐basal microtubules elongate 















1.2.2 Cell Movement: Convergent Extension  
Convergent Extension (CE) is the morphogenetic process responsible for drawing the neural 
folds towards the midline. CE occurs by the active intercalation of cells to narrow and lengthen a 
tissue (Fig. 1.3). During CE, cells intercalate in both radial and mediolateral directions (Fig. 1.3). 
Radial intercalation drives epiboly, the thinning of multilayered tissues, and is responsible for 
increasing the area of the ectoderm during early Xenopus gastrulation (Fig. 1.3A) (Marsden and 
DeSimone, 2001; Keller et al, 2008). Radial intercalation precedes mediolateral intercalation in both 
the mesoderm and the neural plate, but both processes cannot be identified as a distinct 
morphogenetic process in these tissues. During mediolateral CE, an oriented field of cells 
intercalates to form a mediolateral narrow (convergent) and elongated (extension) tissue (Fig. 1.3B). 
In Xenopus, CE is well described in the dorsal mesoderm where cells develop bipolar 
mediolateral lamellipodial protrusions (Fig. 1.4). The lamelliform protrusions bind to adjacent cells 
and through traction pull the lateral margins of the field of cells medially. During this process cells 
intercalate among their neighbours, resulting in axial extension. CE in the dorsal mesoderm is 
thought to be primarily responsible for the forces that drive axial extension of the embryo. 
In the lateral neural plate, CE occurs via a slightly different mechanism. Cells are 
monopolarized and intercalate towards the embryonic midline. Similar to what is observed in the 
mesoderm, this process results in mediolateral (ML) narrowing and anteroposterior (AP) axial 
elongation (Fig. 1.5) (Davidson and Keller, 1999; Elul and Keller, 2000).  Interestingly, cells at the 
neural plate midline are pleomorphic. Pleomorphic cells exhibit randomized lamelliform protrusions 
and do not undergo CE (Fig. 1.5). This region is known as the notoplate and during neurulation 
neural plate and notoplate cells do not mix. The notoplate has been observed to undergo dramatic 
axial elongation in association with CE in the underlying mesoderm (Ezin et al, 2003, 2006). At this 
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time, it remains unclear if CE in the neural tissue produces the forces that result in axial extension of 
































Figure 1.3 Radial and mediolateral cell intercalation. (A) Radial intercalation of multi‐layered 
cells increases surface area of tissues. (B) Mediolateral intercalation of cells mediolaterally narrows 
























Figure 1.4 Cell intercalation in the dorsal mesoderm. (A)Multi‐directional lamellipodia (red) of 
pleomorphic cells before polarization. (A) Bipolarized lamellipodia (red) concentrate at the 
mediolateral ends of dorsal mesodermal cells. The dark arrows indicate the direction of mediolateral 
























Figure 1.5 Cell intercalation in the neural plate. Lamellipodia (red) of neural plate cells are 
monopolarized and move toward the notoplate where cells remain pleomorphic. The dark arrows 
indicate medial migration of the cells causing anteroposterior extension (large grey arrows). 


























1.3 Biomechanics of Convergent Extension 
It has been demonstrated that tissues undergoing CE produce considerable pushing forces 
(Moore et al, 1994). The biomechanical forces resulting from CE are generated only through the 
intercalation of cells (Keller and Danilchik, 1988). Biomechanical investigations on tissues during 
neurulation are focused on only those tissues that exhibit CE. 
In tissues undergoing CE, cells send out lamellipodia that adhere and pull against 
neighboring cells. As a consequence of these pulling forces, dorsal mesodermal cells have been 
observed to elongate with an aspect ML ratio of about 2.5 to 3 (Shih and Keller, 1992). Indeed, 
complex computational modeling has shown that lamellipodia have the mechanical capacity to 
cause cell intercalation and give rise to cell elongation (Brodland, 2006; Brodland and Veldhuis, 
2006). Cells undergoing CE are under considerable tensile stress. The elastic properties of the 
cellular cytoskeleton generate tension by resisting elongation of the cell (depicted as springs, Fig. 1.6 
A, B). Actin‐myosin mediated contraction of the cytoskeleton is also believed to further limit 
elongation and increase tension. Recent research shows that Myosin IIB, a cytoskeletal non‐muscle 
myosin II, not only cross‐links actin filaments to maintain cortical integrity and stiffness, but also 
generates contraction by moving along the cortical actin cytoskeleton in the dorsal mesodermal cells 
of Xenopus embryos (Skoglund et al, 2008; Rolo et al, 2009). Cortical contraction resists stretching 
during CE and creates tension. The proposed model that interfacial tension of tissues is attributed to 
cell‐cortex tension is coined as the ‘Differential Interfacial Tension Hypothesis’ (Brodland, 2002). The 
summation of the tension in these cells results in an increase in the mechanical stiffness (the ability 
to resist deformation) of the tissue. Dorsal mesoderm explants undergoing CE increase in stiffness 
by a factor of 3 to 4 times in the anterior‐posterior axis during early gastrulation, between stage 10+ 
and 11.5, from 3 N/m2 to 10 N/m2 (Moore et al, 1995) and increases of more than six‐fold from 13 to 
16 
85 N/m2 between the late‐gastrula (stage 13) and early neural tube stage (stage 22) (Zhou et al, 
2009). 
One of the puzzles of CE is how tissue stiffness increases while cells are actively intercalating. 
This can be explained through the dynamic turnover of cell adhesions. Lamellipodia bind to the rigid 
surface of adjacent cells through small contact points called ‘tractive protrusions’ (red, Fig. 1.6C). 
Turnover of tractive protrusions on adjacent cells allow lamellipodia to pull cells past one another. 
These adhesions generate tension in the cells and stiffness the tissues. At the same time, turnover of 
cell‐cell ‘stiffening adhesions’ (green, Fig. 1.6A, B, D) allow cells to shear past each other and 
maintain stiffness throughout the entire tissue (Keller et al, 2000). These cell‐cell adhesions may 
actually be downregulated (not in amount) by decreases in the dominant cadherin, C‐cadherin, 
activity and if the decrease is blocked, CE fails (Brieher and Gumbiner, 1994; Zhong et al, 1999). The 
difference in tissue tension attributed to the quantitative and qualitative differences in intercellular 
adhesion is known as the ‘Differential Adhesion Hypothesis’ (Foty and Steinberg, 2005). The dynamic 
turnover of both the tractive protrusions and stiffening adhesions allows the intercalation of cells 
















Figure 1.6 Biomechanics of tractive and stiffening adhesions during cell intercalation. (A) 
Dorsal mesodermal cells  are held in an array of bipolarized lamelliform ‘tractive protrusions’ (red) 
and cell to cell ‘stiffening adhesions’ (green). Tension held within the elastic properties of the 
cytoskeleton of the cells is depicted as springs. (B) Similarly, neural plate cells are held in an array of 
monopolarized lamelliform tractive protrusions (red) and cell to cell stiffening adhesions (green). 
Tension held within the elastic properties of the cytoskeleton of the cells is depicted as springs. (C) 
The tension is generated by the polarized protrusive activity (grey arrow) of the lamelliform 
protrusion (light red) on adjacent cells. Tension is transmitted across the cell membrane to the 
cytoskeleton. Dynamic turnover of the tractive protrusions (dark red) allow cells to shear past each 
other while sustaining tensions throughout the tissue. (D) The dynamic turnover of stiffening 
adhesions (green) between cells also allows cells to pass each other during intercalation in a 











1.4 Molecular Control of Convergent Extension: The Planar Cell Polarity (PCP) Pathway 
The Planar Cell Polarity (PCP) pathway, also known as non‐canonical Wnt signaling, 
regulates cell intercalation behaviours during neural tube closure. Wnt signaling is initiated when 
secreted Wnt proteins interact with their cognate Frizzled (Fz) receptor (Bhanot et al, 1996; Yang‐
Synder et al, 1996). Fz recruits the cytoplasmic scaffolding protein Dishevelled (Dsh) to a 
juxtamembrane compartment for activation (Djiane et al, 2000). Dsh acts as a branch point in Wnt 
signaling, with pathways being well characterized in the canonical and non‐canonical/PCP pathways 
(Fig. 1.7). Pathway specificity is determined through DIX, PDZ, and DEP domains of Dsh (Fig. 1.7). The 
DIX and PDZ domains function in the canonical, or Wnt/β‐catenin signaling, pathway resulting in the 
stabilization of cytoplasmic β‐catenin that translocate into the nucleus where it initiates gene 
transcription (Itoh et al, 2005).  
The PDZ and DEP domains function in the non‐canonical or PCP pathway to activate the 
small GTPases Rho and Rac that modulate the actin cytoskeleton and are required for cadherin 
mediated cell‐cell adhesion (Fig. 1.7) (Wallingford and Habas, 2005; Fukata and Kaibuchi, 2001; 
Dzamba et al, 2009). The PCP signaling pathway was first discovered in Drosophila melanogaster, 
where it acts to orient wing hairs (Wong and Adler, 1993; Turner and Adler, 1995).The PCP is now 
recognized to consist of a core cassette of Frizzled (Fz), Strabismus (Stbm), Diego (Dgo), and Prickle 
(Prk), and Dishevelled (Dsh) (Wallingford et al, 2002; Wallingford and Habas, 2005). In Drosophila 
wing cells, PCP establishes distal‐proximal cell polarity through the asymmetric distribution of core 
PCP molecules. In vertebrates, these same molecules work downstream of a Wnt signal to establish 
cell polarity. 
In Xenopus neural tissue, PCP signaling is regulated through XWnt11 and XFx7 and acts to 
polarize lamellipodia required for CE through Rac and Rho activation (Habas et al, 2001, 2003). In 
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the chordamesoderm, Xenopus Brachyury (Xbra) inhibits cell migration by promoting CE through 
activation of downstream target XWnt11 (Kwan and Kirschner, 2003). XWnt11 interacts with XFz7, 
predominantly localized to the neuroectoderm and dorsal mesoderm, to activate XDsh and regulate 
the actin cytoskeleton and consequently cadherin mediated adhesion between embryonic 
blastomeres through Rac and Rho (Habas et al, 2003). Disruption of the PCP pathway by mutations 
of XDsh randomizes mesodermal cell lamellipodia protrusions and inhibits CE (Wallingford and 
Harland, 2001; Wallingford, 2006). Mutation or deletion of the PDZ and DEP domains of Dsh can also 
disrupt CE, while over expression of the DEP domain can rescue downstream of Wnt and Fz (Wong 
et al, 2000). In the Xenopus neural tube, expression of an XDsh mutant that deletes the PDZ and DEP 
domains cause neural folds to elevate abnormally farther apart and are unable to effectively migrate 
toward the midline (Wallingford and Harland, 2002). The data indicates that PCP signaling can 
control the protrusive activity and adhesive properties of cells in tissues undergoing CE. How the 
PCP affects the biomechanical properties of the neural plate during neurulation has not been clearly 




















Figure 1.7 Canonical and Non‐canonical Wnt pathways. (A) Canonical Wnt signaling mediates 
gene transcription by stabilization and accumulation of β‐catenin in the nucleus. (B) Non‐canonical 
Wnt or PCP signaling activates GTPases Rho and Rac to mediate actin cytoskeleton reorganization. 













1.5 Experimental Rationale 
 While both mesoderm and the neural plate undergo CE, current biomechanical studies 
describe the notochord as the primary source of force production during neurulation (Zhou et al, 
2009). However, previous evidence suggest that Xenopus explants without notochords can converge, 
extend, and elongate nearly as well as explants with notochords (Malacinski and Youn, 1981; 
Malacinski and Youn, 1981). This suggests that other tissues contribute to axial elongation in 
Xenopus. As the neural plate also undergoes CE, the possibility exists that this tissue contributes to 
axial elongation. This would suggest that the cell rearrangements in the neural plate can generate 
force.  
My hypothesis is that the forces that help shape the neural plate arise from morphogenetic 
movements in the neural tissue. I will test this hypothesis by measuring the biomechanical 
properties of Xenopus neural tissue at various stages of development. I will also measure these 
properties under experimental conditions that disrupt neurulation. Xenopus laevis embryos are well 
suited to this form of experimental approach as tissues can be easily excised and cultured ex vivo. 
Also, molecular manipulation that induces failed neural tube closure in vivo is easily established in 
Xenopus laevis embryos. 
The objectives of my research were to establish an experimental system to evaluate the 
stiffness of Xenopus neural tissue and then determine what the control mechanisms are that 
regulate tissue stiffness in the neural ectoderm.  In this study, neurulation was disrupted by 
interfering with the PCP pathway and changes in stiffness of the neural plate were measured. 
Dominant‐negative Wnt11 constructs were expressed to interfere with PCP signaling outside the cell. 
PCP signaling was also blocked at the cell membrane by expressing a dominant‐negative Fz7, the 
receptor of Wnt11, and inhibited in cytoplasm using a dominant‐negative Dsh construct. 
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Chapter 2 
Methods and Materials 
2.1 Xenopus laevis Embryos 
Sexually mature Xenopus laevis were purchased from Nasco (Fort Atkinson, Wisconsin) and 
housed in the Department of Biology Aquatic Facility at the University of Waterloo. Female frogs 
were injected with 400 units of human chorionic gonadotropin (HCG) (Sigma, Oakville, Ontario) to 
induce spawning. Eggs were obtained from spawning females and fertilized in vitro by standard 
methods (Sive, 1996). Fertilized embryos were dejellied in 2% cysteine (EMD, Mississauga, Ontario) 
in water and cultured in 0.1X Modified Barth’s Saline (MBS) (1X MBS; 88mM sodium chloride (NaCl), 
1mM potassium chloride (KCl), 0.7mM magnesium sulphate (MgSO4), 1mM HEPES, 5mM sodium 
bicarbonate (NaHCO3), 0.1mM calcium chloride (CaCl2), at pH 7.6. 
 
2.2 Microinjection and Dominant‐negative Injected Embryos 
An XDsh‐delta PDZ construct (XE123), was obtained as a gift from R Moon (University of 
Washington) in the CS2+ vector (Miller et al, 1999b). The construct was linearized with the NotI 
restriction enzyme. A dnXFz7, or XFz7ΔT, construct consisting of a cytoplasmic tail deletion was 
obtained as a gift from S Sumanas (University of Minnesota) in the pT3Ts vector. The XFz7ΔT‐T3TS 
plasmid was linearized using the BamHI restriction enzyme. The dnXWnt11 construct was as a gift 
from J Smith (Cambridge University) in the pSP64TXB vector. The plasmid was linearized using the 
BamHI restriction enzyme. RNA was made by in vitro transcription using mMessage mMachine kit 
(Ambion) according to manufacturer’s instructions (SP6 promoter for XE123 and dnXWnt11, T3 
promoter for dnXFz7).  
25 
Microinjection needles were formed using a Narishige PC‐10 pipette puller (East Meadow, 
New York). Embryos were placed in 0.5X MBS with 4% Ficoll 400 (Sive, 1996) and microinjected with 
a Narishige EM300 pressure injector (East Meadow, New York) with 2ng of either dnXDsh, dnXFz7, 




Explants were taken from stage 11 (early gastrula), 12 (mid gastrula), or stage 13 (late 
gastrula), Xenopus laevis embryos. Embryos were staged according to Nieuwkoop and Faber (1967). 
These stages were chosen to compare stiffness in the neural plate prior to the onset of CE at stage 
11, at the onset of CE, stage 12, and when CE is actively occurring at stage 13. Embryos were 
dissected in Danilchik’s for Amy (DFA) solution (53 mM sodium chloride (NaCl), 32 mM sodium 
gluconate (NaC6H11O7), 5 mM sodium carbonate (Na2C03), 4.5 mM potassium chloride (KCl), 6mM 
HEPES (C8H18N2O4S), 1 mM calcium chloride (CaCl2), 1 mM magnesium sulphate (MgSO4), at pH 8.1), 
plus bovine serum albumin (BSA, 1 mg/ml) to minimize wound healing (Sater et al, 1993). Vitelline 
membranes were removed manually with forceps and eye lash hair knives and hairloops (Keller et al, 
1999) were used to remove dorsal ectoderm. After the epithelium was removed and discarded (Fig. 
2.1 A), the neural ectoderm and mesodermal cell layers were explanted away from the underlying 
endodermal epithelium. This is known as a deep neural over mesoderm explant or neural tissue 
explant (Fig. 2.1 B; Keller et al, 1999). A similar explant that excludes the underlying mesoderm, 
known as deep neural explants, was also made but was more difficult to excise. Since there was no 
significant difference in measured stiffness between deep neural and neural explants (deep neural 
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over mesoderm explants), the more easily explanted neural explants were used for experiments 
































Figure 2.1: Isolation of deep neural over mesoderm explants. The dorsal epithelial layer is 
removed first (A) followed by removal of the deep neural ectoderm attached to the mesoderm from 






















2.4 Apparatus Design and Tensile Measurement 
The apparatus used for measuring stiffness was a redesign of an instrument built for 
measuring tensile forces in Ambystoma mexicanum embryos (Wiebe and Brodland, 2005). After 
dissection, explants were transferred to a plexiglass chamber filled with DFA. Explants were situated 
on a removable platform located at one end of the plexiglass chamber. Two fine parallel stainless 
steel wires, 63 μm in diameter and 50 mm in length, fixed at the opposite end of the chamber ran 
horizontally toward the explant platform (Fig. 2.2 B). The free ends of the wires were glued with 
FLASH brand Thick viscosity cyanoacrylate glue (NorPak Inc, Lolley, Massachusetts) onto the lateral 
ends of explants. The chamber had a wire lifting mechanism where an outside dial controls two 
prongs to lift and lower the free ends of the wires in and out of solution (Fig. 2.2 B). Once the wires 
adhered to the explant, the explant platform was removed allowing the attached explants to float 
free. A vertical fine tungsten needle attached to a staged computer controlled actuator (Zaber 
Technologies Inc., Vancouver, British Columbia) (Fig. 2.2 A) was lowered between the two stainless 
steel wires (Fig. 2.2 C). During testing, the actuator pushed the tungsten needle against the “active 
wire” near the glued explant and stretched the explant placing it under tension (Fig. 2.2 D). The 
actuator was controlled by the “TissueGUI” program (Wiebe and Brodland, 2005). The original 
TissueGUI program moved the active wire slowly at a strain rate of 30% per hour, stretching the 
tissue in approximately 0.1 μm increments while recording images every 15 seconds. An image‐
based feedback system ensured the tissue was being stretched at a constant strain rate of 30% per 
hour by tracking the wire movements to compare the measured distance between the wires of the 
most recent image taken with the preceding image to control the actuators movements in the next 
15 seconds. The TissueGUI2 program was reprogrammed to run in two phases. Phase A runs 
similarly to the original program except it quickly pushes the active wire displacing it 200 μm in 8 
30 
seconds while taking multiple images. Tracking is completed later and reveals that tissues are 
stretched with an average strain rate of about 200% strain per hour. Phase B continues from the end 
of Phase A and uses a similar image‐based feedback system to sustain a constant strain in the 





























Figure 2.2: Experimental equipment and setup. (A) The plexiglass chamber is placed under the 
microscope and the staged computer controlled actuator is placed to the right. (B)The plexiglass 
chamber allows quick lowering of the fine wires to be glued onto the explant. (C) A fine tip tungsten 
needle attached to the actuator is placed between the two wires. (D) An image captured through 
the microscope of the glued explant by the TissueGUI program. The active wire is pushed by the 













2.5 Data Analysis 
The tensile force of explants was calculated from the unpushed “fixed wire” by treating it as 
a cantilever beam with a load at its free end.  The ‘beam equation’ was rearranged to calculate 




Where F is the tensile force, L is the length of the fixed wire, Δd is the displacement of the fixed wire, 
E is the cantilever material’s elastic modulus that is constant, and I is the second moment of inertia 
which is a property of the beam shape and is a constant. 
According to ‘beam theory’, the “active wire” is significantly stiffer than the other fixed wire 
due to needle placement and does not bend due to its shorter length. Tensile stress, the magnitude 
of tensile forces in an area, was calculated by dividing the total tensile force F by the initial cross‐
sectional area ‘A0’ of the tissue. Tensile strain, the amount of stretch in the tissue, was calculated by 
dividing the change in length ΔL by the original length L0. Young’s modulus ‘E’, or the modulus of 
elasticity, representing tissue stiffness, was determined by the slope of a stress verses strain curve 





Our method did not measure explant thickness and limited our analysis to calculating tensile 
stress using surface area rather than cross‐sectional area (A0). This exclusion accounts for my 
stiffness measurements represented in N/m rather than in N/m2 or Pa which are used normally. 
However, when an average explant thickness of 40‐60 microns (personal observations and Zhou et 
al, 2009) was included in my calculations, results were very similar to those reported in previous 
literature. 
Data was normalized to stage 11 ML or AP stiffness of control explants, and standard 
variation was used to calculate error. Student T‐tests were used for statistical analysis and the 


















3.1 Device Modifications 
The greatest challenge was to design a device that could measure the biophysical properties 
of the small and delicate Xenopus embryo. The previous device designed to measure stiffness in 
larger Ambystoma mexicanum embryos (Wiebe and Brodland, 2005) was too bulky to fit under a 
stereoscope and provided little space to work in. We designed a plexiglass chamber that was small 
enough to fit under a stereoscope and still left workable space for embryo manipulation. A 
simplified wire lifting mechanism was incorporated into the chamber that made the gluing process 
faster and ensured the wires were glued on the explants accurately. The final goal was to optimize 
the attachment of the cantilever wires to the embryonic tissue in a consistent way that did not 
cause tissue injury. Two major factors influenced wire attachment: the type of glue and the type of 
wire.  
 
3.1.1 Selection of Adhesives 
The two most important criteria in selecting an adhesive for attaching the cantilever wires 
onto explanted tissues were bond strength under aqueous conditions and a fast cure time. Several 
types of adhesives were tested (Table 3.1). In all situations the wires were coated with adhesive and 
then placed in contact with excised tissue that was immersed in DFA.  
Initially, I tried using Loctite brand adhesives that can be cured through exposure to UV light. 
Loctite UV adhesive 3014 and a related but more viscous adhesive 3016 were used (Table 3.1). 
When submerged in aqueous solution both the UV adhesives were diluted and provided weak 
bonding to the explants after curing (Table 3.1). Next, a fusion protein was used as a biological 
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adhesive. In Xenopus, C‐cadherin is the dominant cell‐cell adhesion molecule expressed during early 
development. C‐cadherin can be expressed in vitro as a GST‐fusion protein and acts as a functional 
adhesive molecule (Brieher and Gumbiner, 1994). However, adhesion required a 20 minute contact 
time and ultimately attachment was too weak to hold the explant under tension (Table 3.1). 
Mr.Sticky’s underwater epoxy is used to attach invertebrates to rock substrates in aquariums and is 
designed to be able to be applied and cured in aqueous environments. Use of this adhesive proved 
impractical as it required a 24 hour cure time (Table 3.1). 
Cyanoacrylate glue was used in previous experiments (Wiebe and Brodland, 2005) and has 
the advantages of a strong bond and fast cure times. In our system the use of cyanoacrylate 
adhesive was complicated by the requirement to attach wires to tissues in an aqueous environment. 
Since cyanoacrylate glues cure rapidly in the presence of water, I experimented with different 
viscosities of this adhesive in an attempt to delay cure times. Low viscosity cyanoacrylate glue, such 
as ZAP PT‐08 and ZAP PT‐02, exhibited beading on the wires that lead to only partial bonding along 
the glue length (Table 3.1). FLASH brand cyanoacrylate glue is more viscous and was the most 
consistent in providing strong attachment (Table 3.1). As such FLASH thick viscosity cyanoacrylate 








Table 3.1: Relative viscosity, cure time, and strength of attachment of wires to tissue 
explants of several types of adhesives. ‘‐’ represents low viscosity, slow cure times (longer than one 
hour), and little to no attachment of wires onto explants. ‘++++’ represents high viscosity, fast cure 
times (less than 3 seconds), strong attachment where explants remained attached to the wires along 










LOCTITE UV Adhesive – 3014 + ++++ + 
LOCTITE UV Adhesive – 3016 + ++++ + 
Mr. Sticky’s Underwater 
epoxy 
+++++ ‐ ‐ 
C‐Cadherin N/A + + 
ZAP PT‐08 (Super Thin 
Viscosity) Cyanoacrylate 
+ ++++ ++ 
ZAP PT‐02 (Medium Viscosity) 
Cyanoacrylate 
++ ++++ ++ 
 
FLASH Thin Viscosity 
Cyanoacrylate 
++ ++++ ++ 
 
FLASH Medium Viscosity 
Cyanoacrylate 
+++ ++++ +++ 
 
FLASH Thick Viscosity 
Cyanoacrylate 




3.1.2 Types of Wires 
 The design of the device relies upon the cantilever properties of two fine wires from which 
the tissue explants were suspended. As the modulus of the materials that these cantilevers are 
made from directly influenced my measurements, it was critical that wire selection be optimized. 75 
μm diameter tungsten wires were tested first. The hydrophobic oxidized surface of the tungsten 
wires caused adhesive beading and the glue cured in a crystalline fashion resulting in irregular and 
weak bonding along the explants (Fig. 3.1A). In an attempt to improve the interaction between the 
adhesive and the wires the tungsten wires were coated with gold/palladium. However, this had no 
discernable effect on the performance of the glue‐wire combination. 
 I also tried stretching glass and plastic into fine fibres. There was no beading of adhesive, 
but it was difficult to consistently make wires of the same thickness and the wires were buoyant and 
unable to break the surface tension of the solution in the chamber. The original experimental design 
(Wiebe and Brodland, 2005) used 125 μm diameter stainless steel wires. However, they were too 
large to fix onto the small Xenopus embryo explants, which were about 750 μm in width. The 
resulting small gap between the large wires often caused cyanoacrylate glue to fix the wire ends 
together. Therefore, the finest stainless steel wires available, which were 63 μm in diameter, were 
purchased. Cyanoacrylate glue applied to these stainless steel wires consistently provided a strong 
















Figure 3.1: Patterns of cured cyanoacrylate glue on tungsten wires versus stainless steel wires. 
(A) Cyanoacrylate glue cured partially along the glue length and in crystallin fashion (red outline) on 
tungsten wires resulting in weak attachment. This is more visible on the ‘fixed’ wire, ‘F’, than the 
‘active’ wire, ‘A’. The explant, ‘E’, is shown glued to these wires. (B) Stainless steel wires provided 










3.2 Preliminary Tests 
Having developed a device capable of holding and stretching explants from Xenopus 
embryos I then evaluated its performance in preliminary experiments.  The original TissueGUI 
program stretched the tissue at a set strain rate of 30% strain/hour. Figure 3.2A shows a 
representative example of a tensile stress versus strain graph (Fig. 3.2A). The linear portion of the 
curve (red box) represents where the tissue was being stretched at a constant strain rate. The slope 
of this linear segment represents the stiffness in N/m (Fig. 3.2B). Stiffness measurements were 
calculated from 48 tests comparing stiffness at developmental stages 11, 12, and 13 (Fig. 3.3). Stage 
11 deep neural explants had an average stiffness of 0.0119 ±0.0073 N/m (n=7) and stage 11 neural 
explants had an average stiffness of 0.0133 ±0.0073 N/m (n=8) (P > 0.05) (Fig. 3.3). Stage 12 neural 
explants had an average stiffness of 0.0152 ±0.0077 N/m (n=21), nearly equivalent to average 
stiffness at stage 13, 0.0151 ±0.0070 N/m (n=12) (P > 0.05) (Fig. 3.3). There is no significant 





















Figure 3.2: Calculation of stiffness with stress (tensile) versus strain graphs (A) Representative 
stress versus strain graph. Each dot on the graph represents a data point collected during the test. 
This particular test was of a neural explant from a stage 11 Xenopus embryo and measured ML 
stifness. The linear portion of the curve is boxed in red. (B) Isolation of the linear portion to calculate 



















Figure 3.3: Average stiffness of Xenopus deep neural and neural tissue explants at different 
development stages.  Average stiffness with standard deviation of preliminary tests at different 
stages. Average stiffness of stage 11 deep neural explants, 0.0119 ±0.0073 N/m, were not 
significantly different from average stiffness of stage 11 neural tissue explants, 0.0133 ±0.0073 N/m, 
(P > 0.05). Average stiffness of neural tissue explants seem to increase from stage 11 to stage 12, 




















3.3 Sources of Error and Variability 
 Based on previous literature it was expected that there would be considerable differences 
between these stages with stiffness measurements ranging from 3 to 10 N/m2 (Moore et al, 1995).  
My data showed no significant differences in stiffness between stages (Fig. 3.3). This suggested that 
our experimental design may not be sensitive enough to discriminate between small changes in 
tissue stiffness.  
 
3.3.1 The Effects of Wound Healing 
 Upon further examination the effects of wound healing, the tendency of explants to curl up 
as to close ‘a wound’, was discovered to be responsible for skewing my results. This effect was 
visible as an initial negative sloping curve in the stress versus strain graphs (representative data 
shown in Fig. 3.4). The negative slope represents a decrease in the gap between the two wires. This 
was exemplified when tests programmed to run at 0% strain/hour exhibited negatively sloping 
linear curves clearly demonstrating that wound healing drew the cantilever wires together (Fig. 3.5). 
Tissue stiffness calculated from the slope was 0.0036 N/m with an average healing rate of 35% 
strain/hr (representative data shown in Figure 3.5). Reprogramming the TissueGUI program to 
stretch tissues at strain rates of 200% strain/hour or above successfully removed the negative slope 

















Figure 3.4: Wound healing. (A) A stress versus strain graph with an initial negative slope (red 
box) that represents a decrease in the gap between the wires. (B) A close‐up of the negative slope 






















Figure 3.5: Tissue stiffness during wound healing. Stress versus strain and strain versus time 
graphs of a test run at 0% strain rate. (A) The negative slope of the curve in this stress versus strain 
graph represents that the wires were being drawn closer together. A slope of ‐0.0051 translates into 
a stiffness of 0.0051 N/m. The black line represents the calculated slope. (B) Strain is plotted against 
time where the slope is used to calculate strain rate of wound healing. This explants had a wound 






















Figure 3.6: High programmed strain rates remove the effects of wound healing. Stress versus 
strain graph of a test run at 200% strain rate to remove the effects of wound healing. The negative 
slope of the curve produced from the effects of wound healing observed in figure 3.4 is removed in 
stress versus strain graphs from tests programmed to run at 200% strain. The increasing strain line 























3.3.2 Slope Determination 
Another source of variability was selecting the linear portion of the rising slope of the stress 
versus strain graphs used to calculate stiffness (Fig. 3.7). Depending on what range of strain the 
linear segments were taken across, the calculated stiffness changed dramatically. Stiffness 
calculated from 0‐2% strain was erratic (Fig. 3.7A) with an average stiffness of 0.0105 ±0.0037 N/m 
(Table 3.2) compared to stiffness calculated above 2% strain (Fig. 3.7B), averaged 0.00433 ±0.0015 
N/m  (Table 3.2). Due to the consistency of stiffness calculations taken from 2% strain to the highest 
strain sustained in tissue, this portion of the curve was used in all subsequent measurements. In 
















Table 3.2: Average stiffness from 0 to 2% strain and 2 to 8% strain of tests run at a strain rate 
of 200%/hr. Stiffness measurements calculated from slopes taken from 0% to 2% strain where 
higher and more variable, three times the standard error, than stiffness measurements taken from 










































































































3.3.3  Clutch‐to‐Clutch Variability 
Slopes after 2% strain were more consistent; however, the actual stress values of the slopes 
covered a wide range. In Figure 3.7B, stress values differed by four‐fold. This high variation was most 
likely due to natural clutch‐to‐clutch variation of the biomechanical properties seen in Xenopus 
embryos (von Dassow and Davidson, 2007). This is most clearly exemplified when the linear slopes 
of stress versus strain data from a variety of embryo clutches are plotted on one stress versus strain 
graph (Fig. 3.8). Data from embryos of the same clutch cluster together. In this graph the clustering 
of two clutches is evident, Test 164 and 165 were explants from embryos of one clutch and Test 171 
and 172 were explants from embryos of another clutch. The tensile stresses of the tissues varied by 
as much as four‐fold, approximately 0.0002 to 0.0004 N/m of tensile stress over 2% to 8% strain in 
Test 172 compared to approximately 0.0008 to 0.001 N/m of tensile stress over 2% to 8% strain in 
Test 164 (Fig. 3.8). Therefore, to limit clutch‐to‐clutch variation the data was normalized by clutch 
before being averaged (as described in methods and materials section). 
 
3.3.4  Limitations of TissueGUI 
A series of tests running at 200% strain/hour compared the stiffness of neural explants from 
stage 11 embryos and stiffness of neural explants from stage 13 embryos in mediolateral (ML) and 
anteroposterior (AP) directions. Data shows ML stiffness, 0.00476 ±0.0013 N/m, is greater than AP 
stiffness, 0.00308 ±0.0011 N/m, at stage 11(P < 0.05). Stage 13 ML stiffness, 0.00350 ±0.0013 N/m, 
was similar to ML stiffness at stage 11 (P > 0.05).  Stage 13 AP stiffness, 0.00130 ±0.0004 N/m, was 
significantly lower than stage 11 AP stiffness (P < 0.05) (Fig. 3.8). Decreased tissue stiffness in later 
stages of development was unlikely (Moore et al, 1995; Zhou et al, 2009) suggesting that my method 










Figure 3.7: Determining slope on stress versus strain plots. Linear segments taken from 0% to 
2% strain and 2% to 6% strain of tests run at a strain rate of 200%/hr. (A) Linear portions taken from 
0% to 2% strain are erratic compared to (B) linear portions taken from 2% to 6% strain. The black 
lines represent calculated slopes. Test 144 and 145 were explants from embryos of one clutch, Test 
157 and 158 were explants from another clutch, and Test 162 and 163 were explants from embryos 




















Figure 3.8:  Evidence for clutch‐to‐clutch variability. Representative data of linear segments 
taken from 2% to 8% strain of tests from two different clutches. Tests 164 and 165 are from one 
clutch and their linear segments are clustered together. This is the same for tests 171 and 172 which 
are from another clutch. This shows clutch‐to‐clutch variation. The magnitude of measured tensile 
stress differs by four‐fold between the two clutches, with 0.0002 to 0.0004 N/m of tensile stress 
over 2% to 8% strain in Test 172 compared to 0.0008 to 0.001 N/m of tensile stress over 2% to 8% 
































Figure 3.9: Directional stiffness of stage 11 and 13 embryos.  Averaged data taken from 2% to 
8% strain shows that ML stiffness is greater than AP stiffness at stage 11 (P < 0.05). At stage 13, ML 
stiffness remains near equal to ML stiffness at stage 11 (P > 0.05), but AP stiffness is significantly 
lower (P < 0.05). The error bars represent the standard error and ‘*’ represent significant differences 


























TissueGUI2 is programmed to run in two phases. Phase A is similar to the method used in 
the previous TissueGUI program except the active wire is displaced 200 µm in 8 seconds. Phase B 
operates at constant strain and was incorporated to TissueGUI2 to provide a comparison to a 
previous method of measuring stiffness in compression studies. In those studies, stiffness was 
measured 3 minutes after application of stress (Moore et al, 1994, 1995; Zhou et al, 2009). A 
representative test is shown in Fig. 3.10. 
The red trace indicates the strain in the explant calculated from wire tracking, and the blue 
trace indicates the tissue tension force. Phase A is represented as a linear curve nearly identical in 
both strain and tension. The quick drop in both traces that occurs at the initiation of Phase B is due 
to blacklash caused by a mechanical gap within the actuator created when changing directions. In 
phase B, strain is held constant within the tissue over time (horizontal red line), but tissue tension 
degrades over time (blue line, Fig. 3.10). This decay represents degradation of tissue integrity over 



















Figure 3.10: Sample data obtained using TissueGUI2. Representative stress and strain versus 
time graph from tests using the TissueGUI2 program. The red graph represents the strain of the 
explant over time and the blue graph represents the measured stress over time. Phase A occurs 
from ‘0’ to the peak (Y‐axis to arrow A) where both strain and tension in the explant are linear. 
Phase B occurs after the peak point (arrow A to arrow B) where strain is held constant and tension in 























3.4.2 Phase A Stiffness Measurements in Wild Type Embryos  
Tissue stiffness was measured from Phase A and normalized to stage 11 ML stiffness to 
minimize clutch‐to‐clutch variation. Raw averages are presented in the Appendix. Averaged 
normalized data reveal increases in stiffness with developmental stage. Average ML and AP stiffness 
which are similar at stage 11 (P > 0.05) and both significantly increase by stage 13 (P < 0.05). ML 
stiffness is significantly greater than AP stiffness at stage 13 (P < 0.05) (Table 3.3, Fig 3.11). 
 
Table 3.3: Average and normalized phase A stiffness measurements of explants at stage 11 
































0.0126 ± 0.0046 
 








0.0249 ± 0.0062 
 








0.0214 ± 0.0053 
 
















Figure 3.11: Tissue stiffness increases with developmental stage. Averaged data normalized to 
stage 11 ML stiffness shows ML stiffness significantly increases from stage 11 (blue) to stage 13 
(green), 1.00 to 2.39 ±0.6 (P < 0.05), and AP stiffness significantly increases from stage 11 (red) to 
stage 13 (purple), 1.06 ±0.4 to 1.94 ±0.4 (P < 0.05). ML stiffness is significantly greater than AP 
stiffness at stage 13 (P < 0.05). Error bars represent standard deviation and ‘*’ indicates significant 
























3.4.3 Phase B Stiffness and Decay 
Stiffness measurements were also taken in Phase B at 190 seconds similar to a previous 
method for measuring stiffness in compression studies. Average data normalized to stage 11 ML 
stiffness exhibit high variability and no trend is visible (raw averages are presented in the Appendix). 
ML and AP stiffness are similar at stage 11 (P > 0.05) and do not significantly change by stage 13 (P > 
0.05). ML stiffness seems to be greater than AP stiffness at stage 13, but the difference is not 
significant (P > 0.05) (Table 3.4, Fig. 3.12).  
 
Table 3.4: Average and normalized phase B stiffness measurements taken at 190 seconds of 


































0.00457 ± 0.0026 
 








0.00822 ± 0.0062 
 








0.00374 ± 0.0019 
 
1.41 ± 0.9 
 
 
The inability to delineate changes in tissue stiffness across developmental stage is likely due 
to the decay in stiffness. Figure 3.13 summarizes normalized average decrease in stiffness from 45 
to 190 seconds and demonstrates that the patterns of decay are unpredictable (raw averages are 
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presented in Appendix). No trends are visible and the data exhibits high variability. The decreases in 
stiffness are not significantly different in both ML and AP directions from stage 11 to 13 (P > 0.05) 
nor significantly different between ML and AP directions at both stages (P > 0.05) (Table 3.5, Fig. 
3.13). 
 
Table 3.5: Average and normalized decrease in stiffness between 45 and 190 seconds of 
































0.000211 ± 0.00022 
 








0.000295 ± 0.00030 
 








0.000355 ± 0.00026 
 




















Figure 3.12: Phase B tissue stiffness measured at 190 seconds. ML stiffness does not 
significantly increase from stage 11 (blue) to stage 13 (green), 1.00 to 2.55 ±1.3 (P > 0.05). Similarly, 
AP stiffness also does not significantly change from stage 11 (red) to stage 13 (purple), 1.25 ±1.3 to 


































Figure 3.13: Tissue stiffness decay in phase B. ML stiffness does not significantly increase from 
stage 11 (blue) to stage 13 (green), 1.00 to 1.53 ±0.6 (P > 0.05). Similarly, AP stiffness also does not 
significantly change from stage 11 (red) to stage 13 (purple), 1.31 ±0.4 to 2.24 ±0.4 (P > 0.05). Error 

























3.4.4 Regulation of Tissue Stiffness by the PCP Signaling Pathway  
 To investigate what the contributions of the planar cell polarity (PCP) pathway were to the 
biomechanical properties of the neural plate, several dominant‐negative constructs were used to 
block PCP signaling at three levels: outside the cell with dnXWnt11 (Tada and Smith, 2000), at the 
cell membrane with dnXFz7 (Sumanas et al, 2000), and in the cytoplasm with dnXDsh (Wallingford 
and Harland, 2001, 2002). Phenotypes of developmental defects are most prominent in embryos 
injected with dnXDsh, which exhibit large abnormally shaped neural plates with neural folds that 
failed to migrate medially (Fig. 3.14). Similarly, embryos injected with dnXWnt11 have large 
abnormally shaped neural plates with enlarged neural folds that also exhibit little medial migration 
(Fig. 3.14). DnXFz7 injected embryos also have large abnormally shaped neural plates with enlarged 
neural folds that exhibit reduced migration towards the midline (Fig. 3.14). At later stages, these 





















Figure 3.14: Phenotypes of early neurula stage embryos expressing dominant‐negative PCP 
pathway constructs. Embryos injected with the dnXDsh (left), dnXWnt11 (middle), and dnXFz7 
(right) are compared to controls of the same clutch at developmental stages 12.5 (early neurulation), 
14, 15, and 17 (late neurulation). Injected embryos show similar phenotypes of developmental 
defects including large and irregularly shaped neural plates, enlarged neural folds, and delayed 
neural fold migration. Neural plates are highlighted in yellow, neural folds are highlighted in blue, 





























Figure 3.15: Phenotypes of late neurula stage embryos expressing dominant‐negative PCP 
pathway constructs. Embryos injected with the dnXDsh (top), dnXWnt11 (middle), and dnXFz7 
(bottom) are compared to controls of the same clutch at developmental stage 20 (late neurulation). 
Injected embryos show similar phenotypes of developmental defects. They are truncated and have 
incomplete neural fold fusion. Neural plates are highlighted in yellow, neural folds are highlighted in 













 Stiffness was measured in explants obtained from injected embryos as well as sibling 
controls (uninjected). Stiffness measured from dnXDsh injected embryos is compared to measured 
stiffness of control embryos first (Table 3.6, Fig. 3.16, raw averages are presented in the Appendix). 
Data was normalized to stage 11 ML stiffness of controls to limit clutch‐to‐clutch variation. Average 
normalized data reports that in control embryos average ML and AP stiffness are similar at stage 11 
(P > 0.05) and do not significantly increase by stage 13 (P > 0.05). In dnXDsh injected embryos, ML 
and AP stiffness seem to decrease from stage 11 to stage 13  but these differences are not 



















































0.0132 ± 0.0071 
 
 








0.0184 ± 0.0053 
 
 



























0.0171 ± 0.0048 
 
 








0.0165 ± 0.0019 
 
 








0.0156 ± 0.0033 
 
 








0.0126 ± 0.0049 
 
 
0.85 ± 0.4 
 
 
Stiffness measurements from dnXFz7 injected compared to stiffness measured from control 
embryos (Table 3.7, Fig. 3.17, raw averages are presented in the Appendix) exhibit different trends 
as those seen in dnXDsh injected embryos. In controls, average normalized ML and AP stiffness 
seem to increase from stage 11 to stage 13, but only ML stiffness increases significantly (P < 0.05). 
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Average normalized ML and AP stiffness of dnXFz7 injected embryos show no increases in stiffness 
from stage 11 to 13 (P > 0.05) (Table 3.7, Fig. 3.17). 
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Tissue stiffness of dnXWnt11 injected embryos are compared to stiffness of control embryos 
last (Table 3.8, Fig. 3.18, raw averages are presented in the Appendix). Average normalized tissue 
stiffness of control embryos significantly increases from stage 11 to stage 13 (P < 0.05) in both ML 
and AP directions. There are no increases in ML and AP stiffness seen in dnXWtn11 injected embryos 
(P > 0.05) across these stages (Table 3.8, Fig. 3.18). The dnXWnt11 construct produces the most 
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When comparing the overall stiffness of controls (blue) to dnXDsh (red), dnXFz7 (green), and 
dnXWtn11 (purple) injected embryos in ML orientation, significant increases in stiffness from stage 
11 to 13 (P < 0.05) visible in control embryos are not seen in injected embryos (Table 3.9, Fig. 3.19, 
raw averages are presented in the Appendix). ML stiffness in dnXDsh injected embryos seems to 
decrease from stage 11 to 13 and increase in dnXFz7 injected embryos; however, these differences 
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are not significant (P > 0.05). Stiffness in embryos injected with dnXWnt11 constructs are similar at 
stage 11 and 13 (P > 0.05) (Table 3.9, Fig. 3.19). 
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 Similar trends are seen when comparing the overall stiffness in the AP orientation. 
Significant increases in AP stiffness of control embryos (blue) from stage 11 to 13 (P < 0.05) are not 
exhibited by dnXDsh (red), dnXFz7 (green), and dnXWnt11 (purple) injected embryos. Embryos 
injected with dnXDsh, dnXFz7, or dnXWnt11 constructs seem to increase from stage 11 to 13 but the 
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Figure 3.16: The effects of a dnXDsh construct on tissue stiffness. ML and AP stiffness 
measurements of control and dnXDsh injected embryos shows no trend. ML stiffness does not 
significantly differ from stage 11 (blue columns) to stage 13 (green columns) in control embryos, 1.0 
to 1.14 ±0.3 (P > 0.05), and dnXDsh injected embryos, 1.40 ±0.8 to 1.15 ±0.2 (P > 0.05).  AP stiffness 
does not significantly differ from stage 11 (red columns) to stage 13 (purple columns) in control 
embryos, 1.17 ±0.8 to 1.30 (P > 0.05), and dnXDsh injected embryos, 1.26 ±0.78 to 0.96 ±0.43 (P > 































Figure 3.17: The effects of a dnXFz7 construct on tissue stiffness. ML stiffness from stage 11 
(blue columns) to stage 13 (green columns) significantly increases in control embryos, 1.0 to 1.61 (P 
< 0.05), but not in dnXFz7 injected embryos, 1.01 ±0.1 to 1.20 ±0.1 (P > 0.05).  AP stiffness does not 
significantly differ from stage 11 (red columns) to stage 13 (purple columns) in control embryos, 
0.94 ±0.2 to 1.34 ±0.4 (P > 0.05), and dnXFz7 injected embryos, 1.03 ±0.2 to 1.12 ±0.2 (P > 0.05). 
































Figure 3.18: The effects of a dnXWnt11 construct on tissue stiffness. ML stiffness from stage 11 
(blue columns) to stage 13 (green columns) significantly increases in control embryos, 1.0 to 3.48 (P 
< 0.05), but not in dnXWnt11 injected embryos, 2.20 ±1.1 to 2.78 (P > 0.05).  Similarly, AP from stage 
11 (red columns) to stage 13 (purple columns) significantly increases in control embryos, 1.84 ±0.24 
to 3.04 (P < 0.05), but not in dnXWnt11 injected embryos, 2.26 ±1.2 to 2.97 (P > 0.05). Error bars 




























Figure 3.19: Average ML and AP stiffness of explants obtained from embryos with disrupted 
PCP signaling. (A) Medial‐lateral tissue stiffness measurements. Average data is normalized to stage 
11 ML stiffness of controls. Stiffness significantly increases from stage 11 to 13 (blue columns), 1.0 
to 1.79 ±1.0 (P < 0.05), in control embryos. There are no significant differences in stiffness from 
stage 11 to 13 in dnXDsh injected embryos (red columns), 1.40 ±0.8 to 1.15 ±0.2 (P > 0.05), dnXFz7 
injected embryos (green columns), 1.01 ±0.1 to 1.20 ±0.1 (P > 0.05), and dnXWnt11 injected 
embryos (purple columns), 2.20 ±1.1 to 2.78 (P > 0.05). Error bars represent standard deviation and 
‘*’ indicates significant differences (P < 0.05). (B) Anterior‐posterior tissue stiffness measurements. 
Average data is normalized to stage 11 AP stiffness of control embryos. Stiffness significantly 
increases from stage 11 to 13 (blue columns), 1.0 to 1.78 ±0.7 (P < 0.05), in control embryos. There 
are no significant differences in stiffness from stage 11 to 13 in dnXDsh injected embryos (red 
columns), 1.26 ±1.1 to 1.51 ±1.4 (P > 0.05), dnXFz7 injected embryos (green columns), 1.11 ±0.1 to 
1.24 ±0.5 (P > 0.05), and dnXWnt11 injected embryos (purple columns), 1.28 ±0.82 to 1.77 (P > 0.05). 











 A primary objective of this study was to establish an experimental system to evaluate the 
biomechanical properties of Xenopus neural tissue. An experimental system was successfully 
developed sensitive enough to measure the mechanical stiffness of embryonic Xenopus neural 
tissue. After determining stiffness of control embryo neural plates, neurulation was disrupted by 
interrupting the PCP pathway. Resulting changes in neural plate stiffness were measured to 
determine if the forces that shape the neural plate arise from within the neural plate. I propose that 
cell rearrangements in the neural plate generate forces that contribute to neurulation in Xenopus. 
 
4.1 Device Optimization 
 Measurement of tissue mechanical properties from small and delicate embryonic tissues 
requires construction of custom devices (Moore et al, 1994, 1995; Keller et al, 2000; Zhou et al, 
2009). Our approach was to modify a device previously used to measure tissue stiffness in 
Ambystoma mexicanum embryos. The first modification made was to simplify the functional 
components of the device and ensure that the device was small enough to fit under a 
stereomicroscope. This was accomplished by milling a plexiglass chamber that incorporated a wire 
lifting mechanism and modifying the method of wire separation with the actuator using a tungsten 
needle (Fig. 2.1). 
 As this device measures tissue stiffness by attaching fine cantilever wires onto explanted 
tissues, the strength and consistency of attachment were optimized by investigating different types 
of wire and adhesives. Selection of the type of adhesive used for gluing was based on the ability to 
provide strong bond strength with tissues under aqueous solution. Attachment needed to be strong 
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enough to hold explants while they were being stretched. The adhesives utilized are described in 
Table 3.1. UV adhesives became dilute under aqueous conditions, resulting in a bond too weak to 
support tissue explants. Biological adhesive C‐cadherin and Mr. Sticky’s Underwater Epoxy bond 
underwater in aqueous environments but require long cure times. A fast cure time was essential to 
maximize the number of tests that could be completed and ensure tests were conducted at 
desirable embryonic stages. Cyanoacrylate glue was found to provide the greatest bond strength 
and had the fastest cure times (Table 3.1). However, cyanoacrylate glue was difficult to use because 
it cured quickly in contact with aqueous solution. Higher viscosity cyanoacrylate glues delay curing 
under aqueous solution and provided greater consistently and stronger attachment. FLASH brand 
thick viscosity cyanoacrylate glue was the most viscous and had the strongest attachment overall 
and was used in all experiments. 
Wire selection was based on material and modulus. The 125 µm wires used in the original 
design were too large for gluing onto 750 μm Xenopus explants. Cyanoacrylate glue would often 
glue the ends of large wires together because of the proximity of the wires. Finer wires maximized 
the area of the explanted tissue from which I could measure stiffness and reduced the tendency to 
glue wire ends together. Finer 75 µm wires tungsten were used to overcome this problem; however, 
I discovered that the material properties of wires also affected gluing. The hydrophobic oxidized 
surface of the tungsten wires caused cyanoacrylate glue to bead and the glue cured in a crystalline 
fashion causing irregular and weak bonding along the explants (Fig. 3.1A). Uniform attachment 
along the glue length was important to ensure an accurate measurement of stiffness. Incomplete 
attachment reduced the area of the explant that was actually under tension and resulted in an 
underestimation of calculated stiffness. Altering the surface material properties of the tungsten 
wires with gold/palladium did not improve glue strength. There was no beading of cyanoacrylate 
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glue on glass and plastic fibres but glass and plastic were too buoyant and unable to break the 
surface tension of the solution in the chamber. Stainless steel wires allowed smooth coats of glue to 
form on the wire that improved attachment strength along the glue length of the explant (Fig. 3.1B). 
The finest manufactured stainless steel wires I could find were 63µm in diameter and these were 
used to manufacture cantilevers in all experiments. 
 
4.2 Experimental Parameters 
 Preliminary data from initial tests that measured stiffness along the ML axis at 30% strain/hr 
find neural explants from developmental stages 11 (mid‐gastrula), 12, and 13 (late‐gastrula) are not 
significantly different with an average stiffness of 0.0014 N/m and large standard deviation of 
±0.0015 N/m (P > 0.05) (Fig. 3.3). Only neural explants were compared at later stages because 
average stiffness measurements of deep neural and neural explants at stage 11 (mid‐gastrula) were 
not significantly different (P > 0.05) (Fig. 3.3). Also, neural explants were easier and required less 
time to excise from whole embryos. It should be noted that my stiffness measurements are 
reported in N/m because we do not take into account the thickness of the tissue being stretched, 
but if an average explant thickness of 40‐60 microns (Zhou et al, 2009) is incorporated into the 
calculations, very similar numbers to those reported in previous literature are obtained. However, 
my preliminary data did not coincide with previous findings. Xenopus axial dorsal mesoderm has 
been shown to increase in stiffness during CE. Stiffness increases in both ML and AP directions 
during early gastrulation with increases as much as three‐fold from 3 N/m2 at stage 10+ to 10 N/m2 
at stage 11.5 in the AP axis (Moore et al, 1995). A more recent study (Zhou et al, 2009) reports AP 
stiffness increases of more than six‐fold from 13 to 85 N/m2 between the late‐gastrula (stage 13) to 
early neural tube stage (stage 22) suggesting that there is a significant increase in mesodermal 
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stiffness through early development. Expected increases in stiffness with progressing developmental 
stage were not seen in preliminary tests and suggested our experimental design was not sensitive 
enough to discriminate between small changes in tissue stiffness.  
 While investigating potential sources of error, wound healing was discovered to be the 
primary source of error in my experiments. Wound healing occurs in explanted tissue to curl up the 
tissue into a ball as if to close a wound. In fact, studies show that isolated mesodermal tissue 
behaves much like a liquid droplet to form a spherical shape to minimize surface area and surface 
tension (Ninomiya and Winklbauer, 2008). In my experiments, wound healing contracts tissues to 
draw the two cantilever wires together and was visible in stress versus strain graphs as an initial 
negative sloping curve (Fig. 3.4). In tests programmed to idle at 0% strain/hr, wound healing 
produced negatively sloping linear curves in stress versus strain graphs, meaning the gap between 
the wires was decreasing at a steady rate (Fig. 3.5). This effect produced an artificial tissue stiffness 
calculated to be 0.0036 N/m and had an average healing rate of 35% strain/hr (representative data 
shown in Figure 3.5). A wound healing rate of 35% strain/hr acts against a programmed strain rate 
of 30% strain/hr in TissueGUI and masks any differences in tissue stiffness measured across 
embryonic stages (Figure 3.3). The apparent stiffness of the healing tissue is greater than the 
stiffness values recorded indicating that unless the effects of healing were compensated for 
obtaining meaningful results would be impossible. Wound healing was not an expected source of 
error and had not been seen in other systems that rely on compression to determine stiffness and 
therefore may not have been able to discriminate the contracting tissues (Moore et al, 1995; Zhou 
et al, 2009). To compensate for the effects of wound healing, I experimented with tests 
programmed to stretch tissues at higher strain rates. A strain rate of 200% strain/hr provided the 
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maximum number of data points while successfully limiting the effects of wound healing and 
removing the negative slope seen at the beginning of stress versus strain graphs (Fig 3.6). 
 In trouble shooting the effects of wound healing, I also examined discrepancies in the 
criteria used to select the linear portions of stress versus strain graphs to calculate stiffness (slope) 
(red box, Fig. 3.2). For tests programmed to run at 200% strain/hr, calculated stiffness changed 
dramatically depending on what range of strain the linear segments were taken across. Stiffness 
calculated from 0‐2% strain (Fig. 3.7A) had higher values and larger errors compared to stiffness 
calculated above 2% strain (Fig. 3.7B and Table 3.2). Stiffness calculations taken from 0‐2% strain 
may be unreliable due to remaining effects of wound healing. Wound healing begins the moment 
tissues are excised from whole embryos. By the time wires are glued onto the explant for testing 
some wound healing has already occurred for a few minutes. Therefore, data points at early stages 
of testing at 0‐2% strain would be affected the most by wound healing. Stiffness calculations taken 
from 2% strain to the highest strain sustained in tissues before tearing, usually 8% strain, were more 
consistent and became the standard method for calculating stiffness. 
Although the effects of wound healing are overcome after 2% strain by high programmed 
strain rates of 200%, I continued to find a wide range of actual stress values from slopes taken after 
2% strain (Fig. 3.7B) that result in high variation of calculated stiffness. It was determined that the 
variation was due to high clutch‐to‐clutch variation. A clear example of clutch‐to‐clutch variation is 
seen in Figure 3.8 where tests of explants from embryos of two different clutches are plotted on the 
same stress versus strain graph. Linear slopes from embryos of the same clutch cluster together and 
measured tensile stresses between clutches can differ by as much as four‐fold (Fig. 3.8). 
Inconsistencies in biomechanical properties of Xenopus embryos have been documented (von 
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Dassow and Davidson, 2007, 2009). During data analysis, clutch‐to‐clutch variation was 
compensated for by normalizing data within each clutch before taking averages. 
 Tests run at 200% strain/hr find that average stiffness calculated from 2% to 8% strain did 
not increase in the ML direction from stage 11 to 13 (P > 0.05) and AP stiffness actually decreased (P 
< 0.05) (Fig. 3.9). Again, these results were inconsistent with previous findings that describe 
increasing ML and AP stiffness in neural tissue with greater increases in the AP direction (Moore et 
al, 1995; Zhou et al, 2009). Also, a greater AP stiffness at later stages was expected (Moore et al, 
1995); however, my results find ML stiffness to be significantly greater than AP stiffness at stage 11 
and at stage 13 (P < 0.05) (Fig. 3.9). Our method of measuring stiffness was limited and how data 
was being collected needed to be reconsidered. It was decided that data would be collected at high 
instantaneous strain rates to limit the effects of wound healing. Collecting data at the moment 
stress is applied also provided a standard method for calculating slope (stiffness) for every test that 
brought consistency within clutches. Data would also be collected following instantaneous strain 
measurements where strain is maintained at a constant rate in the tissue to provide a direct 
comparison of my data to that collected by previous researchers (Moore et al, 1994, 1995; Zhou et 
al, 2009). These programming changes were subsequently named Tissue GUI2. TissueGUI2 is 
programmed to run in two phases. Phase A is similar to the method used in the previous TissueGUI 
program except the active wire is displaced 200 µm to stretch the tissue in 8 seconds. Phase B 
(constant strain) was incorporated to TissueGUI2 to provide a comparison to a previous method of 
measuring stiffness in compression studies where stiffness is measured 180 seconds after 
application of stress, known as the 180‐second stress‐relaxation protocol  (Moore et al, 1994, 1995; 
Zhou et al, 2009). 
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4.3 Directional Stiffness of the Neural Plate 
Measured Phase A stiffness of control embryos from tests using TissueGUI2 show that 
average ML and AP stiffness are similar at stage 11 (P > 0.05) and increase significantly at stage 13 (P 
< 0.05) (Fig. 3.11A). These differences remain significant when data is normalized to stage 11 ML 
stiffness to reduce clutch‐to‐clutch variation (P < 0.05) (Fig. 3.11B). Increases in stiffness with 
progressing developmental stage seen are consistent with previous studies (Moore et al, 1995; Zhou 
et al, 2009). Although the molecular details of how the cytoskeleton generates the tensile forces 
pulling the cells between one another remain unclear. Evidence suggests tension originates from the 
cortical actin‐myosin cytoskeleton generated by the tugging of cells through the protrusive activity 
of lamellipodia and active actin‐myosin‐mediated contraction that shorten and limit cell elongation. 
Computer modeling suggests that tractoring through lamellipodia protrusions has the mechanical 
capacity to drive CE (Brodland, 2006; Brodland and Veldhuis, 2006). F‐actin, long filamentous 
polymers of actin, exhibit dynamic elastic properties (Gardel et al, 2006) and non‐muscle myosin II 
has been found to co‐localize with F‐actin and generate forces that contribute to dorsal closure in 
Drosophila embryos (Franke et al, 2005). In Xenopus myosin IIB localizes to the cortex of 
intercalating cells acting to cross‐link actin filaments and maintain cortical stiffness. MyosinIIB could 
possibly generate contraction within the cortical actin cytoskeleton in the dorsal mesodermal cells 
(Skoglund et al, 2008; Rolo et al, 2009). This attributes increases in tissue tension to tension 
generated in the cell‐cortex, a mechanism that has been described as the ‘Differential Interfacial 
Tension Hypothesis’ (Brodland, 2002). As the neural plate undergoes CE it is possible that the 
tension generated by cell contractility may contribute to the increase in tissue stiffness I observe in 
my experiments. 
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Furthermore, tissue tension may also be mediated by cell‐cell adhesion. A recent study 
(Krieg et al, 2008) addresses the ‘Differential Adhesion Hypothesis’ (Foty and Steinberg, 2005) using 
atomic force microscopy (AFM). In zebrafish embryos they determine that E‐cadherin mediated cell‐
cell adhesion was highest in mesodermal cells and lowest in ectodermal cells, with endoderm cells 
displaying intermediate levels of cell adhesion. In cell sorting experiments the tissue with the 
highest cell‐cell adhesion levels did not engulf the tissue with the lower levels of cell‐cell adhesion. 
However, the same study reveals cell‐cortex tension is driven by acto‐myosin contraction and was 
highest in ectodermal cells, intermediate in mesodermal cells, and lowest in endodermal cells and 
ectoderm cells engulf mesoderm cells, suggesting cell‐cortex tension has a greater influence in cell 
sorting experiments (Krieg et al, 2008). Taken together it is certainly possible that cell‐cortex tension 
may play a role in mediating tissue stiffness in my experiments independent of cell‐cell adhesion. 
Contrary to previous literature, my data indicates there is greater ML stiffness at stage 13 
than at stage 11 (P < 0.05). This finding suggests that the current assumption that AP stiffness is 
greater than ML stiffness at later stages (Moore et al, 1995) may be premature as it compares ML 
and AP stiffness in early‐gastrula stage embryos (Moore et al, 1995).  I am making a comparison of 
stiffness between the axial orientations of late‐gastrula or neural stage Xenopus embryos and it is 
likely my results are due to measurements taken at a later developmental stage. The observed 
differences may also be due to differences in methodology as I stretched tissues and they 
compressed tissues. Due to their structure some molecules may resist tension but not compression 
(Vincent, 1990). The sub‐cellular structures that support tension in neural cells, including the myosin 
filaments, actin filaments, microtubules, and cell‐cell adhesion molecules may behave differently 
when compressed, as opposed to when they are stretched, accounting for the difference between 
my observations and those collected in compression. Differences in directional stiffness may also 
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depend on differences in the intercalation of cells in mesoderm (bipolar) and in the neural plate 
(monopolar). Bipolar intercalation occurs in all dorsal mesodermal cells undergoing CE, but in the 
neural plate monopolar intercalation occurs only in lateral neural cells of the neural plate and occurs 
towards the notoplate (midline) where cells remain pleomorphic (Elul et al, 2000; Ezin et al, 2003, 
2006). Notoplate cells do not exhibit cell intercalation and the notoplate is thought to extend along 
the AP axis through attachment to the underlying notochord (Ezin et al, 2003). Pleomorphic cells of 
the notoplate are unlikely to contribute in generating forces that drive CE causing AP axial 
elongation in the neural plate and may be responsible for lower AP stiffness measured in my 
experiments. My results clearly demonstrate neural plate tissues have biomechanical properties 
that contribute to morphogenesis and that these are distinct from those found in mesoderm. 
In an attempt to further validate our methodology, I also took measurements over a similar 
time course t previous studies (Moore et al, 1995; Zhou et al, 2009). A 180‐second stress‐relaxation 
protocol for measuring stiffness is used in compression tests. Stiffness is measured 180 seconds 
after compression (Moore et al, 1995; Zhou et al, 2009). Measurements were taken at this time as 
they found the tissue responded to compression and at 180 seconds this response had subsided. 
When I measured stiffness in Phase B of my experiments, average and normalized ML and AP 
stiffness was not significantly different from stage 11 to 13 (P > 0.05) although my results exhibit 
high variation (Fig. 3.12). The high variation from measurements taken in phase B is similar to the 
variation seen in compression studies (Moore et al, 1995; and Zhou et al, 2009). One of the 
advantages of my approach is that my experiments demonstrate this variance is due to the decay in 
stiffness over time (Fig. 3.10). As constant strain is sustained within the tissue (red line, Fig. 3.10) 
stress is observed to decrease over time (blue line, Fig. 3.10). A decrease of stress in the tissue 
represents a decrease in tissue stiffness. Decay in stiffness likely results from natural degradation of 
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tissue integrity over time in response to stress. Explants that have been stretched twice exhibit a 
much lower stiffness the second time suggesting the mechanical properties of the tissue have 
degraded due to stress (data not shown). The amount of decay that occurs is variable in phase B, 
meaning the rates at which tissues degrade are unpredictable. This is most evident in the raw data 
separated by clutch (Fig. A1.2A and Fig. A1.3A). For example, AP stiffness at stage 11 of clutch 7 
embryos was unusually higher than stiffness at stage 13 (Fig. A1.2A). This was due to greater decay 
at stage 13 than at stage 11 of clutch 7 embryos (Fig. A1.3A). Similar observations have been made 
in compression studies in mesoderm (von Dassow and Davidson, 2007, 2009). Furthermore, 
limitations of our experimental method may contribute to variable amounts of degradation of tissue 
stiffness. Gluing may not always result in complete attachment of the wires to the tissue explant and 
it is observed that attachment weakens over time and the explant eventually separates from the 
wires. Tearing of the tissue at the site of attachment during testing has also been observed and may 
be a source of degradation of stress seen in Phase B.  
The 180‐second stress‐relaxation protocol for measuring stiffness used in compression 
studies refers to this decay as tissue ‘response’ to applied stress and measurements are taken at 180 
seconds after the ‘response’ subsides (Moore et al, 1995). Similar patterns of decay are observed in 
my analysis where degradation seems to plateau as stress approaches zero. However, decay or 
‘response’ never completely subsides and waiting for degradation to settle seemed impractical. The 
sources of degradation are unknown, but I demonstrate it can account for unreliable stiffness 





4.4 PCP Affects Neural Plate stiffness 
 The  PCP pathway is known to regulate CE in the neural plate (Habas et al, 2001; Habas et al, 
2003) and the disruption of PCP signaling randomizes lamellipodia (Wallingford and Harland, 2001; 
Wallingford, 2006). When PCP is disrupted neural tissue cannot generate the forces required for 
proper neurulation (Keller et al, 2008). It is expected that blocking PCP signaling would eliminate the 
differences in stiffness in neural tissue in the ML versus AP orientation. I first looked at the 
phenotypic effects of disrupting PCP signaling by using a dominant‐negative constructs to block PCP 
signaling at three levels: outside the cell with dnXWnt11 (Tada and Smith, 2000) at the cell 
membrane with dnXFz7 (Djiane et al, 2000) and in the cytoplasm with dnXDsh (Wallingford and 
Harland, 2001, 2002). Phenotypes of injected embryos were similar exhibiting large abnormally 
shaped neural plates with neural folds that had little medial migration compared to controls (Fig. 
3.14). At stage 17 (early‐neurula stage), injected embryos were truncated compared to sibling 
controls and possessed neural tube defects. The ability of the neural folds to elevate was not 
affected suggesting apical constriction occurred normally in the neural plate. Control embryos 
exhibit AP elongation and have closed neural tubes (Fig. 3.15). Injected embryos have open neural 
tubes and exhibit little AP elongation (Fig. 3.15). The shortened axis and lack of medial neural fold 
medial migration indicates that there has been a generalized failure in CE movements in the embryo. 
My dominant negative construct injections target the neural plate and it is therefore likely that this 
failure stems from the disruption of the biomechanical properties of the neural plate. 
To determine what effects disrupting PCP had on the biomechanical properties of the neural 
plate, I measured stiffness in explants derived from injected embryos as well as controls from the 
same clutch. After normalizing to stage 11 ML stiffness of controls, ML and AP stiffness exhibit 
increases from stage 11 to 13 in control embryos (P < 0.05) (blue, Fig. 3.19B and Fig. 3.20B) 
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correlating well with my previous results. Embryos injected with dnXDsh (red), dnXFz7 (green), and 
dnXWnt11 (purple) constructs exhibits no increases in ML and AP stiffness from stage 11 to 13 (P > 
0.05) (Fig. 3.19B and Fig. 3.20B). Disrupting PCP outside the cell, at the cell membrane, and inside 
the cell by expressing dnXWnt11, dnXFz7, and dnXDsh indicates that failure of CE is directly 
correlated with decreases in forces generated in the neural plate. As disruption of PCP signaling 
leads to decreased Rac and Rho function the decreased stiffness maybe due to misregulation of the 
cortical actin cytoskeleton. In vertebrates, apical accumulation of Rho in the neural plate is required 
for cell shape change and proper neural tube formation (Kinoshita et al, 2008). Furthermore 
decreased actin reorganization randomizes lamellipodia (Wallingford and Harland, 2001; 
Wallingford, 2006). Neural cells with randomized lamellipodia would behave similarly to 
pleomorphic cell and do not exhibit polarized traction. In the presence of dominant negative 
constructs uncoordinated protrusive activity of the lamellipodia inhibits cell intercalation disrupting 
CE and results in no increases in stiffness through stage 11 to 13. Also, decreased cytoskeletal 
reorganization during CE would compromise cell‐cortex tension. In Xenopus, inhibiting myosin IIB 
function disrupts cortical actin cytoskeleton polarity and reduces cell‐cell adhesion (Skoglund et al, 
2008) and reduced F‐actin or Myosin II contractility reduces AP stiffness in dorsal tissues by 50 
percent in a dose‐dependent manner (Zhou et al, 2009). This supports PCP’s role in modulating the 
biomechanical properties of the neural plate and shows that forces that shape neural plate arise 
from within it. However, how XWnt11, XFz7, and XDsh exactly function to modulate the 
biomechanical properties or the generation of these forces in the neural plate is still unknown. 
My study provides evidence and a quantitative measure of the differences in the 
biomechanical properties of the neural plate regulated by XWnt11, XFz7, and XDsh. Although the 
differences are not significant, an apparent increase in stiffness of dnXDsh and dnXWnt11 injected 
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embryos compared to controls at stage 11 is a common trend observed when comparing both ML 
and AP stiffness (Fig. 3.19B and Fig. 3.20B). Normalized data comparing dnXDsh injected and control 
embryos (Fig. 3.16B) exhibit the same trend; however, expected increases in stiffness with stage in 
controls are not significant (P > 0.05 ) and most likely due natural variations in biomechanical 
properties of Xenopus embryos. Normalized data comparing dnXWnt11 injected and control 
embryos do exhibit expected increases in both ML and AP stiffness from stage 11 to 13 in controls (P 
< 0.05) and exhibits a trend, similar to dnXDsh experiments, of greater ML and AP stiffness of 
dnXWnt11 injected embryos than controls at stage 11 (Fig. 3.18B). Conversely, normalized data 
comparing dnXFz7 injected and control embryos exhibit similar ML and AP stiffness at stage 11 (Fig. 
3.17B). ML and AP stiffness of dnXFz7 injected embryos remains similar to controls at stage 11. 
These trends may be explained by the differences in the molecular function of Wnt, Fz, and 
Dsh. Since Fz functions primarily as Wnt’s receptor signaling downstream to activate Dsh 
(Wallingford and Habas, 2005) its disruption would be the most specific in interrupting PCP signaling 
and failed CE. ML and AP stiffness are similar between control and dnXFz7 injected embryos at stage 
11 prior to the onset of CE. At stage 13, control embryos exhibit increases in ML and AP stiffness due 
to active CE while dnXFz7 injected embryos exhibit no increases in stiffness due to disrupted CE. 
Wnt proteins function in multiple signaling pathways that control several aspects of development 
including proliferation, fate specification, polarity, and migration of cells (reviewed by Logan and 
Nusse, 2004). Disrupting Wnt11 function with the construct that I used could potentially block many 
Wnt pathways as how the construct acts is unclear. Therefore, reasons for the apparent increases in 
ML and AP stiffness of dnXWnt11 injected embryos compared to controls at stage 11 exhibited in 
my experiments are unclear. Wnt11 is known to regulate the turnover of cadherins and if this is 
disrupted it may result in increased cell‐cell adhesion. This could be clarified with experiments that 
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examine the turnover of C‐cadherin in the embryo. However, increases in ML and AP stiffness in 
controls from stage 11 to 13 are not exhibited by dnXWnt11 injected embryos suggesting disruption 
of CE. Similarly, ML and AP stiffness measurements of dnXDsh injected and control embryos show 
the same trend. Disruptions of Dsh would also have a variety of effects as it functions in not only in 
PCP signaling, but also in canonical Wnt signaling (reviewed by Wallingford and Habas, 2005). In 
canonical Wnt signaling, Dsh signals downstream to block cytoplasmic β‐catenin phosphorylation. β‐
catenin accumulates and traffics into the nucleus to initiate transcription of a variety of Wnt‐target 
genes (Itoh et al, 2005). Other non‐conical pathways, such as Wnt‐Ca2+ signaling, that may influence 
the canonical and PCP pathways have been emerging (Miller et al, 1999a; Wallingford and Habas, 
2005). Therefore the disruption of Dsh is the least specific, making it difficult to decipher how it is 
responsible for the increases seen prior to stage 11. Increased stiffness prior to CE may be 
responsible for failed neural tube closure by creating tissue too stiff for morphogenetic movements 
to occur and the tissue then resists deformation. An initial stiffer tissue may explain wider neural 
folds exhibited in injected embryos. It is possible that a temporal and spatial optimal level of 
stiffness is necessary for proper neurulation to occur. This is supported by the observation that 
stimulation and inhibition of the PCP leads to the same phenotypes (Roszko et al, 2009). Ultimately, 
my experiments reinforce PCP’s role in modulating the biomechanical properties of the neural plate 







 4.5 Conclusion 
 We were successful in developing an experimental method to measure tissue stiffness in 
Xenopus embryos. The design was sensitive enough to discriminate small differences in stiffness 
between mediolateral and anteroposterior axial orientations, as well as developmental stage. My 
experiments describe the forces behind wound healing, and are the first observation that describes 
this process in mechanical terms. Control embryos show equivalent stiffness in both the ML and AP 
axis measurements at stage 11 before CE occurs. Stiffness increased at stage 13 coincident with CE, 
with greater stiffness in the ML direction. Embryos injected with dominant‐negative constructs of 
Wnt11, Fz7 and Dsh, showed little change in stiffness in both ML and AP directions. This suggests 
PCP is responsible for modulating or initiating these differences. Overall, this study provides 
evidence that the forces that shape the neural plate arise from within neural tissue. 
 
4.6 Future Direction 
The optimization of this device opens many avenues for the investigation of the 
biomechanical forces in embryonic tissues. The use of the device is limited only by the size of the 
tissue in question. Immediate questions that arise from my work are: does the neural plate continue 
to become stiffer with more advanced developmental stage? If so, how do ML and AP stiffness 
compare at later stages? What is the source of the stiffness in the ML direction? How does PCP 
regulate tissue stiffness? Future experiments could investigate the effects of over‐expression or 
knockout of Wnt, Fz, and Dsh and if the effects could be rescued using downstream PCP molecules 
such as Rac and Rho. Answering these questions will lead to a better understanding of how 
















Average Stiffness (N/m) 




11 ML 0.0115 ± 0.0014 
11 AP 0.00893 ± 0.0034 
13 ML 0.0312 ± 0.011 
13 AP 0.0238 ± 0.012 
 
6 
11 ML 0.0098 ± 0.0039 
11 AP 0.0122 ± 0.0055 
13 ML 0.0222 ± 0.0036 
13 AP 0.0182 ± 0.0046 
 
7 
11 ML 0.0074 ± 0.0048 
11 AP 0.0133 ± 0.0032 
13 ML 0.0221 ± 0.0076 
13 AP 0.0175 ± 0.00092 
 
9 
11 ML 0.0155 ± 0.0012 
11 AP 0.0160 ± 0.00049 
13 ML 0.0251 ± 0.0045 
13 AP 0.0232 ± 0.0049 
 
Average 
11 ML 0.0128 ± 0.0059 
11 AP 0.0126 ± 0.0046 
13 ML 0.0249 ± 0.0062 






Figure A1.1: Average Phase A stiffness of explants at stage 11 and 13 in ML and AP directions. 
(A) Phase A stiffness measured in embryos from four separate clutches (clutch 4, 6, 7, and 9). ML 
stiffness increased from stage 11 (blue) to stage 13 (green) in all clutches: 0.0115 ±0.0014 N/m to 
0.0312 ±0.011 N/m (P > 0.05) in clutch 4, 0.0098 ±0.0039 N/m to 0.0222 ±0.0036 N/m (P > 0.05) in 
clutch 6, 0.0074 ±0.0048 N/m to 0.0221 ±0.0076 N/m (P > 0.05) in clutch 7, and 0.0155 ±0.0012 N/m 
to 0.0251 ±0.0045 N/m (P > 0.05) in clutch 9. Similarly, AP stiffness increased from stage 11 (red) to 
stage 13 (purple) in all clutches: 0.00893 ±0.0034 N/m to 0.0238 ±0.012 N/m (P > 0.05) in clutch 4, 
0.0122 ±0.0055 N/m to 0.0182 ±0.0046 N/m (P > 0.05) in clutch 6, 0.0133 ±0.0032 N/m to 0.0175 
±0.00092 N/m (P > 0.05) in clutch 7, 0.0160 ±0.00049 N/m to 0.0232 ±0.0049 N/m (P > 0.05) in 
clutch 9. Error bars represent standard deviation. (B) Increases in ML and AP stiffness from stage 11 
to 13 are exhibited when data is averaged across clutches and the differences are significant (P < 
0.05). Average ML stiffness increases from 0.0128 ±0.0059 N/m at stage 11 (blue) to 0.0249 ±0.0062 
N/m at stage 13 (green) (P < 0.05). Similarly, average AP stiffness increases from 0.0126 ±0.0046 
N/m at stage 11 (red) to 0.0214 ±0.0053 at stage 13 (purple) (P < 0.05). Error bars represent 








Table A1.2: Average Phase B (190 seconds) stiffness of explants at stage 11 and 13 in ML and 










Average Stiffness (N/m) 




11 ML 0.00390 ± 0.0016 
11 AP 0.00298 ± 0.0012 
13 ML 0.0168 ± 0.010 
13 AP 0.00540 ± 0.0029 
 
6 
11 ML 0.00407 ± 0.0011 
11 AP 0.00418 ± 0.0031 
13 ML 0.00885 ± 0.00099 
13 AP 0.00403 ± 0.0046 
 
7 
11 ML 0.000981 ± 0.0012 
11 AP 0.00441 ± 0.00041 
13 ML 0.00247 ± 0.0029 
13 AP 0.00264 ± 0.00021 
 
9 
11 ML 0.00525 ± 0.0031 
11 AP 0.00601 ± 0.0011 
13 ML 0.00633 ± 0.0034 
13 AP 0.00309 ± 0.0015 
 
Average 
11 ML 0.00560 ± 0.0048 
11 AP 0.00457 ± 0.0026 
13 ML 0.00822 ± 0.0062 









Figure A1.2: Average Phase B (190 seconds) stiffness of explants at stage 11 and 13 in ML and 
AP directions. (A) Phase B stiffness measured in embryos from clutch 4, 6, 7, and 9 showed high 
variability and no trends. There are no significant differences in ML stiffness from stage 11 (blue) to 
stage 13 (green) in all clutches: 0.00390 ±0.0016 N/m to 0.0168 ±0.010 N/m (P > 0.05) in clutch 4, 
0.00407 ±0.0011 N/m to 0.00885 ±0.00099 N/m (P > 0.05) in clutch 6, 0.00981 ±0.0012 N/m to 
0.00247 ±0.0029 N/m (P > 0.05) in clutch 7, and 0.00525 ±0.0031 N/m to 0.00633 ±0.0034 N/m (P > 
0.05) in clutch 9. Similarly, there are no significant differences in AP stiffness from stage 11 (red) to 
stage 13 (purple) in all clutches: 0.00298 ±0.0012 N/m to 0.00540 ±0.0029 N/m (P > 0.05) in clutch 4, 
0.00418 ±0.0031 N/m to 0.00403 ±0.0046 N/m (P > 0.05) in clutch 6, 0.00441 ±0.00041 N/m to 
0.00264 ±0.00021 N/m (P > 0.05) in clutch 7, 0.00601 ±0.0011 N/m  to 0.00309 ±0.0015 N/m (P > 
0.05) in clutch 9. Error bars represent standard deviation. (B) Averaged data across clutches reveals 
high variability and no trend. Average ML stiffness changes from 0.00560 ±0.0048 N/m at stage 11 
(blue) to 0.00822 ± 0.0062 N/m at stage 13 (green) (P > 0.05). Average AP stiffness changes from 
0.00457 ±0.0026 N/m at stage 11 (red) to 0.00374 ±0.0019 at stage 13 (purple) (P > 0.05). Error bars 








Table A1.3: Average decrease in stiffness between 45 and 190 seconds of explants at stage 11 










Average Stiffness (N/m) 




11 ML 0.000259 ± 0.00020 
11 AP 0.000169 ± 0.00020 
13 ML 0.00000365 ± 0.00016 
13 AP 0.000148 ± 0.00024 
 
6 
11 ML 0.0000817 ± 0.00014 
11 AP 0.000258 ± 0.00018 
13 ML 0.000202 ± 0.00011 
13 AP 0.000472 ± 0.00033 
 
7 
11 ML 0.000389 ± 0.000088 
11 AP 0.000224 ± 0.000081 
13 ML 0.000765 ± 0.00038 
13 AP 0.000464 ± 0.000037 
 
9 
11 ML 0.000166 ± 0.00029 
11 AP ‐0.0000288 ± 0.000089 
13 ML 0.000274 ± 0.00013 
13 AP 0.000236 ± 0.00024 
 
Average 
11 ML 0.000126 ± 0.00022 
11 AP 0.000211 ± 0.00022 
13 ML 0.000295 ± 0.00030 








Figure A1.3: Average decrease in stiffness between 45 and 190 seconds of explants at stage 11 
and 13 in ML and AP directions. (A) Decrease in stiffness measured in embryos from clutch 4, 6, 7, 
and 9 exhibited high variability and demonstrates that the patterns of decay are unpredictable. 
Decreases in ML stiffness are not significantly different (P > 0.05) from stage 11 (blue) to stage 13 
(green) embryos in all clutches: 0.000259 ±0.00020 N/m to 0.00000365 ±0.00016 N/m (P > 0.05) in 
clutch 4, 0.0000817 ±0.00014 N/m to 0.000202 ±0.00011 N/m (P > 0.05) in clutch 6, 0.000389 
±0.000088 N/m to 0.000765 ±0.00038 N/m (P > 0.05) in clutch 7, and 0.000166 ±0.00029 N/m to 
0.000274 ±0.00013 N/m (P > 0.05) in clutch 9. Similarly, there are no significant differences in 
decreases in AP stiffness from stage 11 (red) to stage 13 (purple) in all clutches: 0.000169 ±0.00020 
N/m to 0.000148 ±0.00024 N/m (P > 0.05) in clutch 4, 0.000258 ±0.00018 N/m to 0.000472 
±0.00033 N/m (P > 0.05) in clutch 6, 0.000224 ±0.000081 N/m to 0.000464 ±0.000037 N/m (P > 
0.05) in clutch 7, ‐0.0000288 ±0.000089 N/m  to 0.000236 ±0.00024 N/m (P > 0.05) in clutch 9. Error 
bars represent standard deviation. (B) Averaged data across clutches reveals high variability and no 
trend to demonstrate that he patterns of decay are erratic. Average ML stiffness changes from 
0.000126 ±0.00022 N/m at stage 11 (blue) to 0.000295 ±0.00030 N/m at stage 13 (green) (P > 0.05). 
Average AP stiffness changes from 0.000211 ±0.00022 N/m at stage 11 (red) to 0.000355 ±0.00026 
























Control 11 ML 0.00787 ± 0.00050 
Control 11 AP 0.0157 ± 0.0045 
dnXDsh injected 11 ML 0.0185 ± 0.0060 




Control 11 ML 0.0156 ± 0.00091 
Control 11 AP 0.00721 ± 0.0021 
Control 13 ML 0.0216 ± 0.0083 
Control 13 AP 0.0207 ± 0.0034 
dnXDsh injected 11 ML 0.0158 ± 0.0050 
dnXDsh injected 11 AP 0.0178 ± 0.00082 
dnXDsh injected 13 ML 0.0198 
dnXDsh injected 13 AP 0.0181 
 
13 
Control 13 ML 0.0175 ± 0.0014 
Control 13 AP 0.0155 ± 0.0044 
dnXDsh injected 13 ML 0.0130 ± 0.00068 




Control 11 ML 0.0158 ± 0.0053 
Control 11 AP 0.0166 ± 0.011 
Control 13 ML 0.0141 
Control 13 AP 0.0203 
dnXDsh injected 11 ML 0.0132 
dnXDsh injected 11 AP 0.00581 
dnXDsh injected 13 ML 0.0164 
dnXDsh injected 13 AP 0.00857 








Control 11 ML 0.0131 ± 0.0047 
Control 11 AP 0.0132 ± 0.0071 
Control 13 ML 0.0184 ± 0.0053 
Control 13 AP 0.0185 ± 0.0039 
dnXDsh injected 11 ML 0.0163 ± 0.0045 
dnXDsh injected 11 AP 0.0144 ± 0.0051 
dnXDsh injected 13 ML 0.0156 ± 0.0033 



















Figure A2.1: Average stiffness measured from dnXDsh injected embryos compared to sibling 
controls. (A) Average stiffness measured from dnXDsh injected embryos compared to sibling 
controls by clutch. Trends are difficult to determine due to high variation. At stage 11, average 
stiffness measured: 0.00787 ±0.00050 N/m in ML and 0.0157 ±0.0045 N/m in AP for control 
embryos, 0.0185 ±0.0060 N/m in ML and 0.0152 ±0.0018 N/m in AP for dnXDsh injected embryos of 
clutch 11; 0.0156 ±0.00091 N/m in ML and 0.00721 ±0.0021 N/m in AP for control embryos, 0.0158 
±0.0050 N/m in ML and 0.0178 ±0.00082 N/m in AP for dnXDsh injected embryos of clutch 12; 
0.0158 ±0.0053 N/m in ML and 0.0166 ±0.011 N/m in AP for control embryos, 0.0132 N/m in ML and 
0.00581 N/m in AP for dnXDsh injected embryos of clutch 14. At stage 13 average stiffness 
measured: 0.0216 ±0.0083 N/m in ML and 0.0207 ±0.0034 N/m in AP for control embryos, 0.0198 
N/m in ML and 0.0181 N/m in AP for dnXDsh injected embryos of clutch 12; 0.0175 ±0.0014 N/m in 
ML and 0.0155 ±0.0044 N/m in AP for control embryos, 0.0130 ±0.00068 N/m in ML and 0.0111 N/m 
in AP for dnXDsh injected embryos of clutch 13; 0.0141 N/m in ML and 0.0203 N/m in AP for control 
embryos, 0.0164 N/m in ML and 0.00857 N/m in AP for dnXDsh injected embryos of clutch 14. Error 
bars represent standard deviation. (B) Average stiffness measured from dnXDsh injected embryos 
compared to sibling controls across clutches. Trends are difficult to determine due to high 
variability; however, a significant increase in ML stiffness from stage 11 (blue) to stage 13 (green) 
not exhibited in dnXDsh injected embryos, 0.0163 ±0.0045 N/m to 0.0156 ±0.0033 N/m(P > 0.05), is 
exhibited in control embryos, 0.0131 ±0.0047 N/m to 0.0184 ±0.0053 N/m (P < 0.05). No significant 
differences are seen in AP stiffness from stage 11 (blue) to stage 13 (green) of control embryos, 
0.0132 ±0.0071 N/m to 0.0185 ±0.0039 N/m(P > 0.05), or of dnXDsh injected embryos, 0.0144 
±0.0051 N/m to 0.0126 ±0.0049 N/m (P > 0.05). Error bars represent standard deviation and ‘*’ 






















Control 11 ML 0.0103 ± 0.0051 
Control 11 AP 0.00809 ± 0.0093 
Control 13 ML 0.0168 ± 0.0016 
Control 13 AP 0.0164 ± 0.0016 
dnXFz7 injected 11 ML 0.00938 ± 0.00085 
dnXFz7 injected 11 AP 0.00954 
dnXFz7 injected 13 ML 0.0130 




Control 11 ML 0.0122 ± 0.0014 
Control 11 AP 0.0135 ± 0.000068 
Control 13 ML 0.0193 ± 0.0037 
Control 13 AP 0.0132 ± 0.0045 
dnXFz7 injected 11 ML 0.0134 ± 0.00092 
dnXFz7 injected 11 AP 0.0139 ± 0.0017 
dnXFz7 injected 13 ML 0.0137 ± 0.010 







Control 11 ML 0.0113 ± 0.0032 
Control 11 AP 0.0125 ± 0.0057 
Control 13 ML 0.0180 ± 0.0027 
Control 13 AP 0.0148 ± 0.0033 
dnXFz7 injected 11 ML 0.0114 ± 0.0024 
dnXFz7 injected 11 AP 0.0140 ± 0.0039 
dnXFz7 injected 13 ML 0.0135 ± 0.0074 




Figure A2.2: Average stiffness measured from dnXFz7 injected embryos compared to sibling 
controls. (A) Average stiffness measured from dnXFz7 injected embryos compared to sibling 
controls by clutch. Trends are difficult to determine due to high variation. At stage 11, average 
stiffness measured: 0.0103 ±0.0051 N/m in ML and 0.00809 ±0.0093 N/m in AP for control embryos, 
0.00938 ±0.00085 N/m in ML and 0.00954 N/m in AP for dnXFz7 injected embryos of clutch 16; 
0.0122 ±0.0014 N/m in ML and 0.0135 ±0.000068 N/m in AP for control embryos, 0.0134 ±0.00092 
N/m in ML and 0.0139 ±0.0017 N/m dnXFz7 injected embryos of clutch 17. At stage 13, average 
stiffness measured: 0.0168 ±0.0016 N/m in ML and 0.0164 ±0.0016 N/m in AP for control embryos, 
0.0130 N/m in ML and 0.0128 ±0.00041 N/m in AP for dnXFz7 injected embryos of clutch 16; 0.0193 
±0.0037 N/m in ML and 0.0132 ±0.0045 N/m in AP for control embryos, 0.0137 ±0.010 N/m in ML 
and 0.0121 ±0.0057 N/m in AP for dnXFz7 injected embryos of clutch 17. Error bars represent 
standard deviation. (B) Average stiffness measured from dnXFz7 injected embryos compared to 
sibling controls across clutches. Trends are difficult to determine due to high variability; however, a 
significant increase in ML stiffness from stage 11 (blue) to stage 13 (green) not exhibited in dnXFz7 
injected embryos, 0.0114 ±0.0024 N/m to 0.0135 ±0.0074 N/m(P > 0.05), is exhibited in control 
embryos, 0.0113 ±0.0032 N/m to 0.0180 ±0.0027 (P < 0.05). No significant differences are seen in AP 
stiffness from stage 11 (blue) to stage 13 (green) of control embryos, 0.0125 ±0.0057 N/m to 0.0148 
±0.0033 N/m(P > 0.05), or of dnXFz7 injected embryos, 0.0140 ±0.0039 N/m to 0.0125 ±0.0033 N/m 



























Control 11 ML 0.00994 
Control 11 AP 0.0199 
dnXWnt11 injected 11 ML 0.0143 ± 0.0024 




Control 11 ML 0.00573 ± 0.0013 
Control 11 AP 0.00959 ± 0.00072 
Control 13 ML 0.0200 ± 0.0055 
Control 13 AP 0.0174 ± 0.0098 
dnXWnt11 injected 11 ML 0.0169 ± 0.0026 
dnXWnt11 injected 11 AP 0.0179 ± 0.0067 
dnXWnt11 injected 13 ML 0.0159 ± 0.0028 







Control 11 ML 0.0071 ± 0.0026 
Control 11 AP 0.0130 ± 0.0060 
Control 13 ML 0.0200 ± 0.0055 
Control 13 AP 0.0174 ± 0.0098 
dnXWnt11 injected 11 ML 0.0156 ± 0.0026 
dnXWnt11 injected 11 AP 0.0159 ± 0.0063 
dnXWnt11 injected 13 ML 0.0159 ± 0.0028 









Figure A2.3: Average stiffness measured from dnXWnt11 injected embryos compared to sibling 
controls. (A) Average stiffness measured from dnXWnt11 injected embryos compared to sibling 
controls by clutch. Trends are difficult to determine due to high variation. At stage 11, average 
stiffness measured: 0.00994 N/m in ML and 0.0199 N/m in AP for control embryos, 0.0143 ±0.0024 
N/m in ML and 0.0139 ±0.0075 N/m in AP for dnXWnt11injected embryos of clutch 18; 0.00573 
±0.0013 N/m in ML and 0.00959 ±0.00072 N/m in AP for control embryos, 0.0169 ±0.0026 N/m in 
ML and 0.0179 ±0.0067 N/m dnXWtn11 injected embryos of clutch 19. At stage 13, average stiffness 
measured: 0.0200 ±0.0055 N/m in ML and 0.0174 ±0.0098 N/m in AP for control embryos, 0.0159 
±0.0028 N/m in ML and 0.0170 ±0.0086 N/m dnXWtn11 injected embryos of clutch 19. Error bars 
represent standard deviation. (B) Average stiffness measured from dnXWnt11 injected embryos 
compared to sibling controls across clutches. Trends are difficult to determine due to high variability. 
There are no significant differences in ML stiffness from stage 11 (blue) to stage 13 (green) of 
control embryos, 0.0071 ±0.0026 N/m to 0.0200 ±0.0055 N/m(P > 0.05), or of dnXWnt11 injected 
embryos, 0.0156 ±0.0026 N/m to 0.0159 ±0.0028 N/m (P > 0.05). No significant differences are seen 
in AP stiffness from stage 11 (blue) to stage 13 (green) of control embryos, 0.0130 ±0.0060  N/m to 
0.0174 ±0.0098 N/m(P > 0.05), or of dnXWnt11 injected embryos, 0.0159 ±0.0063 N/m to 0.0170 
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